10x Genomics
TXG
$41.91
Share price
-7.77%
Change (1 day)
-1.16%
Change (1 year)
Categories
10x Genomics (TXG) - P/B ratio
P/B ratio as of September 2023 : 6.20
According to 10x Genomics
's latest financial reports the company has a price-to-book ratio of 6.20.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
10x Genomics - P/B ratio (from 2019 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 5.18 | -74.57% |
| 2021-12-31 | 20.4 | -1.28% |
| 2020-12-31 | 20.6 | 18.02% |
| 2019-12-31 | 17.5 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.05 | -83.05% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 1.49 | -76.00% | 🇬🇧 UK |
 Novavax NVAX | -0.9107 | -114.68% | 🇺🇸 USA |
 Novocure
NVCR | 4.51 | -27.27% | Jersey |